High-throughput screening (HTS) is an established method in drug discovery by which hundreds of thousands of compounds are screened in an automated fashion for activity as inhibitors or activators of ...

Developing new pharmaceuticals is a complex and costly process that requires innovation and efficiency. High-throughput immunoassays (HTIs) are an emerging technology poised to accelerate the drug ...

Martin Clasby receives funding from the National Institutes of Health and Michigan Drug Discovery. Modern drug discovery is an expensive and complicated process. Hundreds of scientists and at least a ...

The utilization of 3D organoids is increasingly prevalent in disease modeling and drug discovery due to their ability to better represent biologically relevant tissue architecture, microenvironments, ...